Soros Fund Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-48,200
Closed -$738K 378
2014
Q1
$738K Buy
+48,200
New +$738K 0.01% 236